Results With New Agents, New Approaches Highlighted At ASCO Annual Meeting
Taxol Plus Carboplatin Increased Survival Of NSCLC In Patients 70 And Older
New Therapies Could Benefit Patients With Difficult Cancers
Radiation Improves Survival In Advanced Prostate Cancer
Survivors With Gene Variant At More Risk For Heart Disease
ASCO, FDA Website To Help Demystify Expanded Access
NCI Trials Listed
Trending Stories
- Prediction markets now allow betting on clinical trial results, FDA decisions
It’s a high-risk bet: Insider trading, equipoise, integrity of research, public trust are at stake - Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Pour a Scotch, we’re talking clinical trials and prediction markets
- Retraction is not refutation: Why chrono-immunotherapy still deserves scientific investigation
- Mount Sinai oncologist Krystal Cascetta, 40, and her infant daughter die in Somers, NY, home









